These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12060823)

  • 1. Evaluation of bone metastases in lung cancer. Improved sensitivity and specificity of PET over bone scanning.
    Malhotra P; Berman CG
    Cancer Control; 2002; 9(3):254, 259-60. PubMed ID: 12060823
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
    Cheran SK; Herndon JE; Patz EF
    Lung Cancer; 2004 Jun; 44(3):317-25. PubMed ID: 15140545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients].
    Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
    Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
    J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.
    Schirrmeister H; Arslandemir C; Glatting G; Mayer-Steinacker R; Bommer M; Dreinhöfer K; Buck A; Hetzel M
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):964-8. PubMed ID: 14991241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer presenting with solitary bone metastases. Case 2: acrometastasis as an initial presentation of non-small-cell lung carcinoma.
    Jänne PA; Datta MW; Johnson BE
    J Clin Oncol; 1999 Sep; 17(9):2998-3001. PubMed ID: 10561378
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone metastases and lung cancer recurrence on (99m)Tc-depreotide imaging.
    Meristoudis G; Ilias I; Batsakis C; Christakopoulou J
    Hell J Nucl Med; 2008; 11(3):185-6, author reply 186. PubMed ID: 19081868
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Foo SS; Ramdave S; Berlangieri SU; Scott AM
    Australas Radiol; 2004 Jun; 48(2):214-6. PubMed ID: 15230758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.
    Michel F; Solèr M; Imhof E; Perruchoud AP
    Thorax; 1991 Jul; 46(7):469-73. PubMed ID: 1652164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramedullary metastasis detected with 18F FDG-PET/CT.
    Sari O; Kaya B; Kara Gedik G; Ozcan Kara P; Varoglu E
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a role of whole body bone scan in early stages of non small cell lung cancer patients.
    Iordanidou L; Trivizaki E; Saranti S; Georgakopoulos A; Bolanos N; Baltagiannis N; Koutsiouba P
    J BUON; 2006; 11(4):491-7. PubMed ID: 17309183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer.
    Erturan S; Yaman M; Aydin G; Uzel I; Müsellim B; Kaynak K
    Chest; 2005 Feb; 127(2):449-54. PubMed ID: 15705981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron-emission tomography (PET) superior to computed tomography for staging and detecting metastasis.
    Timms B
    Eur J Cancer; 2000 Oct; 36(15):1888. PubMed ID: 11186437
    [No Abstract]   [Full Text] [Related]  

  • 17. PET in lung cancer staging.
    Coleman RE
    Q J Nucl Med; 2001 Sep; 45(3):231-4. PubMed ID: 11788815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are symptoms reliable as an indication for the necessity of bone scans in lung cancer metastases?
    Wong R
    Nat Clin Pract Oncol; 2004 Nov; 1(1):18-9. PubMed ID: 16264792
    [No Abstract]   [Full Text] [Related]  

  • 19. Detecting extrathoracic metastases in patients with non-small cell lung cancer: Is routine scanning necessary?
    Metintas M; Ak G; Akcayir IA; Metintas S; Erginel S; Alatas F; Yildirim H; Kurt E; Ozkan R
    Lung Cancer; 2007 Oct; 58(1):59-67. PubMed ID: 17566597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of non-small-cell lung cancer with positron-emission tomography.
    Donckier JE; Roelants V; Pochet JM
    N Engl J Med; 2000 Nov; 343(21):1572; author reply 1572-3. PubMed ID: 11184751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.